Top

memo - Magazine of European Medical Oncology

Published in:

01-03-2018 | editorial

memo—publisher’s report 2017

Author: Alois Sillaber

Published in: memo - Magazine of European Medical Oncology | Issue 1/2018

Excerpt

All issues of the journal memo—Magazine of European Medical Oncology are accessible and available worldwide via the platform SpringerLink (https://link.springer.com/journal/12254). A look at the recent years of this online presence shows how successful the journal is in the electronic world. …

Title: memo—publisher’s report 2017
Author: Alois Sillaber
Publication date: 01-03-2018
Publisher: Springer Vienna
Published in: memo - Magazine of European Medical Oncology / Issue 1/2018
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-017-0379-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2018

Cell free nucleic acids as diagnostic and prognostic marker in leukemia

Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes

Targeting angiogenesis in lung cancer

Correction to: Report from the WCLC 2017 Congress, Yokohama, 15th–18th October, 2017

Short overview on the current standard of treatment in newly diagnosed multiple myeloma

Antiangiogenic therapies in ovarian cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer